Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001707451-17-000006
Filing Date
2017-10-05
Accepted
2017-10-04 17:58:25
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-1 AMENDMENT axium_s1a.htm S-1/A 601361
2 ARTICLES OF INCORPORATION, AS AMENDED axium_ex0301.htm EX-3.1 39253
3 LEGAL OPINION axium_s1a-ex0501.htm EX-5.1 9300
4 GRAPHIC image_001.jpg GRAPHIC 4655
5 GRAPHIC image_002.jpg GRAPHIC 2231
6 GRAPHIC image_005.jpg GRAPHIC 5933
7 GRAPHIC image_011.jpg GRAPHIC 10989
8 GRAPHIC image_012.jpg GRAPHIC 22206
9 GRAPHIC image_013.jpg GRAPHIC 5804
10 GRAPHIC image_014.jpg GRAPHIC 21926
11 GRAPHIC image_015.jpg GRAPHIC 5166
  Complete submission text file 0001707451-17-000006.txt   760675
Mailing Address 265 EASTCHESTER DR. SUITE 133, #201 HIGHPOINT NC 27262
Business Address 265 EASTCHESTER DR. SUITE 133, #201 HIGHPOINT NC 27262 888-805-7734
Axium Pharmaceuticals Inc. (Filer) CIK: 0001715028 (see all company filings)

EIN.: 821984738 | State of Incorp.: NC | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-220076 | Film No.: 171122779
SIC: 2836 Biological Products, (No Diagnostic Substances)